GlassScriptPhysician profile
Vincent Joseph Carson
NPI 1659666592
$12,364.34
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,594 · 2020: $84.76 · 2021: $155 · 2022: $2,237 · 2023: $112 · 2024: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $9,581.36 | 2019-2024 | Spinraza |
| Genentech, INC. | $2,145.00 | 2022 | |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $135.89 | 2019-2022 | |
| Greenwich Biosciences, INC. | $105.13 | 2019-2020 | |
| Genzyme Corporation | $61.32 | 2023 | |
| Ptc Therapeutics, INC. | $49.90 | 2021 | |
| Genentech USA, INC. | $45.93 | 2022-2024 | Evrysdi |
| Sarepta Therapeutics, INC. | $33.13 | 2019 | |
| Biomarin Pharmaceutical INC. | $27.87 | 2023 | Palynziq |
| Neurelis, INC. | $26.71 | 2020-2021 | |
| Rhythm Pharmaceuticals, INC. | $23.52 | 2022 | |
| Novo Nordisk INC | $23.20 | 2022 | |
| Ucb, INC. | $22.76 | 2024 | Nayzilam |
| Baxter Healthcare | $21.90 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $21.05 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $20.48 | 2024 | Daybue |
| Philips North America LLC | $19.19 | 2024 | (Ak6) Vest Therapy |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Carson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.